Electrocardiogram teletransmission and teleconsultation: essential elements of the organisation of medical care for patients with ST segment elevation myocardial infarction: a single centre experience

Abstract

An ECG teletransmission and teleconsultation system reduces the system delay. ECG teletransmission systems work well in rural areas with low population density and a single large PCI-capable hospital. With increasing experience, a gradual increase in the effectiveness of management protocols involving ECG teletransmission is seen.

Standard 12-lead electrocardiogram tele-transmission: Support in diagnosing cardiovascular diseases in operations undertaken by Warsaw-area basic medical rescue teams between 2009 and 2013

“…Polish original data on ACS patients referred to invasive cardiology lab hospitals using the ECG tele-transmission and tele-consultation system has shown a significant reduction of the delay in implementing effective treatment. An upward trend is shown in almost 10-year experience of the members participating in the system [12].…”

Paramedic versus physician-staffed ambulances and prehospital delays in the management of patients with ST-segment elevation myocardial infarction

“…A meta-analysis of non-randomized studies on pre-hospital ECG transmission demonstrated reduction of absolute time to reperfusion by 19 to 114 min which represented a 19% to 56% relative time reductions (95% CI from -33% to -48%; p < 0.001) [17]. Kleinrok et al [20] showed that during an 8-year period more than 7000 ECG transmissions resulted in admission of nearly 1500 STEMI patients. Zimoch et al [19] pointed out that pre-hospital ECG transmission results in a higher rate of patients transferred directly to a PCI center (88% vs. 63%; p = 0.002).…”

Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts’ standpoint

“…A reasonable approach is to begin the treatment with a P2Y12 receptor inhibitor based on the administration timing tested for the drug in the approval studies (i.e. as soon as possible and deemed safe for clopidogrel and ticagrelor, or after the indication for PCI is established based on coronary anatomy for prasugrel in NSTE-ACS) [3,[57][58][59]. In ACS patients treated with CABG, therapy with ticagrelor is preferred due to favourable results in reduction of risk of adverse cardiovascular events, including death rates, as compared with clopidogrel, without increasing the risk of severe CABG-related bleeding [55].…”